Most Recent Articles by Marc Iskowitz
Can agencies prove that regulations no longer hinder Grand Prix-level branded work?
Agency business again appears to be up for a healthy cross-section of companies this year. And, according to our annual business barometer of healthcare firms, the new agency is thriving on a diet of mostly digital work on both the HCP and consumer sides. Meanwhile, the increased emphasis on creating memorable content and patient-centered user experiences appears to be a driving force in pharmaceutical clients' marketing strategy. Marc Iskowitz reports
The emphasis on providing service and value in healthcare has prompted the industry's largest holding companies to fuse their capabilities as they seek to connect this industry's disparate stakeholders. As told to Marc Iskowitz
Fourth and fifth members of network add healthcare advertising and PR expertise.
Medscape marked its 20th anniversary with a reunion this week that attracted staffers from the portal's earliest days.
More Articles by Marc Iskowitz
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.